stockrowArcus Biosciences, Inc.
RCUS Healthcare Biotechnology
Arcus Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $247.0 million, down 4.26% from fiscal 2024.
- Revenue
- −65.4%
- EPS
- +21.3%
- Free cash flow
- +9.28%
- Total debt
- +4.08%
Quarter to September 2026, against a year earlier
Follow RCUS
Alert me
Arcus Biosciences, Inc. (RCUS) Revenue growth
Arcus Biosciences, Inc.'s revenue growth over the twelve months to 30 September 2026 was −58.3%, down 54.1 percentage points from fiscal 2025 (−4.26%). Over the past ten years it has ranged from −83.1% (fiscal 2017) to 491.2% (fiscal 2018); the current reading is higher than 33% of that period. That is below the Biotechnology industry median of 6.26% and below the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | −4.26% | (124.77) |
| FY2024 | 120.5% | 116.05 |
| FY2023 | 4.46% | 75.22 |
| FY2022 | −70.8% | (461.79) |
| FY2021 | 391.0% | (28.97) |
| FY2020 | 420.0% | 340.42 |
| FY2019 | 79.6% | (411.57) |
| FY2018 | 491.2% | 574.23 |
| FY2017 | −83.1% | — |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | −65.4% | 9.00 |
| Jun 2026 | −74.4% | (35.09) |
| Mar 2026 | −39.3% | (66.21) |
| Dec 2025 | 26.9% | 72.75 |
| 33 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| BEAM Beam Therapeutics Inc. compare | 163.3% |
| RXRX Recursion Pharmaceuticals, Inc. compare | 56.2% |
| ZLAB Zai Lab Limited Unsponsored ADR compare | 0.02% |
| NAMS NewAmsterdam Pharma Company N.V. compare | −26.4% |
| XNCR Xencor, Inc. compare | −28.6% |
| RCUS Arcus Biosciences, Inc. | −58.3% |
| IDYA IDEAYA Biosciences, Inc. compare | −83.6% |
| PHVS Pharvaris N.V. compare | — |
| MBX MBX Biosciences, Inc. compare | — |
| Biotechnology industry median | 6.26% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on RCUS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement